Análisis de supervivencia de los pacientes con cáncer de próstata con factores patológicos desfavorables tratados con prostatectomía radical y radioterapia de rescate tras la recidiva y persistencia bioquímica-Reference-Cited by-同舟云学术

Análisis de supervivencia de los pacientes con cáncer de próstata con factores patológicos desfavorables tratados con prostatectomía radical y radioterapia de rescate tras la recidiva y persistencia bioquímica

Published:2020-12 Issue:10 Volume:44 Page:701-707
ISSN:0210-4806
Container-title:Actas Urológicas Españolas
language:es
Short-container-title:Actas Urológicas Españolas

Author:

Barbas Bernardos G.,Herranz Amo F.,González San Segundo C.,Caño Velasco J.,Subirá Ríos D.,Moralejo Gárate M.,Mayor de Castro J.,Aragón Chamizo J.,Hernández Fernández C.

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial;Walsh;J Urol,1997

2. Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial;Br J Urol,1997

3. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: Long-term follow-up;Antonarakis;BJU Int,2012

4. External validation of the EAU BCR risk groups to predict metastasis and mortality after radical prostatectomy in a European cohort;Tilki;Eur Urol.,2019

5. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors for Relapse of Prostate Cancer after Radical Prostatectomy in Chinese Population;UROL J;2024

2. Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer;Clinical and Translational Oncology;2024-04-11

3. Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients;Discover Oncology;2023-12-19

4. Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients;Pharmacogenomics and Personalized Medicine;2021-07

5. Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer;Disease Markers;2020-10-09